67. 多発性嚢胞腎 Polycystic kidney disease Clinical trials / Disease details


臨床試験数 : 216 薬物数 : 219 - (DrugBank : 50) / 標的遺伝子数 : 39 - 標的パスウェイ数 : 151

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2005-003182-16-GB
(EUCTR)
26/08/200529/07/2005Blood Pressure Optimisation In Patients With Polycystic Kidney Disease And Hypertension By Rotation Through The Main Therapeutic Classes Of Antihypertensive Drugs.Blood Pressure Optimisation In Patients With Polycystic Kidney Disease And Hypertension By Rotation Through The Main Therapeutic Classes Of Antihypertensive Drugs. Polycystic kidney diseaseTrade Name: CARDURA
Product Name: DOXAZOSIN
Trade Name: MONOCOR
Product Name: BISOPROLOL
Trade Name: ZESTRIL
Product Name: LISINOPRIL
Trade Name: ISTIN
Product Name: AMLODIPINE
Trade Name: AMIAS
Product Name: CANDESARTAN
Trade Name: APRINOX
Product Name: BENDROFLUMETHIAZIDE
Addenbrooke's Hospital TrustNULLNot Recruiting Female: yes
Male: yes
42 Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): yesUnited Kingdom